摘要
目的研究阿奇霉素和红霉素联合治疗支原体肺炎的临床评价。方法将68例患儿随机分成两组,即对照组和实验组,每组34例,对照组采用阿奇霉素治疗支原体肺炎,实验组在对照组基础上联合应用红霉素治疗支原体肺炎,比较两组患儿临床疗效、临床症状改善时间及住院时间。结果实验组的总有效率高于对照组(97.06%vs79.41%),两组比较差异有统计学意义(P<0.05);实验组患儿的咳嗽消失时间、退热时间、肺部啰音消失时间均少于对照组,两组比较差异有统计学意义(P<0.05);对照组患儿的住院时间高于实验组,两组比较差异有统计学意义(P<0.05)。结论阿奇霉素联合红霉素治疗支原体肺炎有效地改善了患儿的临床症状,提高了临床效果,减少了住院时间,且用药简单,利于患者早日康复。
Objective To study the clinical evaluation for azithromycin, combined with erythromycin in the treatment of mycoplasma pneumonia. Methods Sixty-eight patients were randomly divided into two groups, namely the control group and experimental group, and each group had 34 patients. The control group was treated with azithromycin in treatment of mycoplasma pneumonia, and the experimental group was taken with joint application of erythromycin in the treatment of mycoplasma pneumonia on the basis of the control group. The clinical efficacy, improvement of clinical symptoms and hospitalization time for the two groups were compared. Results The total efficiency rate of the experimental group was higher than that in the control group （97.06% vs 79.41%）, the difference was statistically significant （P 0.05）. The cough disappeared time, fever clearance time, pulmonary rates disappearance times in the experimental group were less than that in the control group, the difference was statistically significant （P 0.05）. The hospital stay of patients in the control group was more than that of the experimental group, the difference was statistically significant （P 0.05）. Conclusion The combination of azithromycin and erythromycin in the treatment of mycoplasma pneumonia is effective to improve the patient＇s clinical symptoms. It improves the clinical results, reduces hospitalization time and medication, which will help the speedy recovery of patients.
出处
《中国当代医药》
2013年第2期82-83,共2页
China Modern Medicine
关键词
阿奇霉素
红霉素
支原体肺炎
临床评价
Azithromycin
Erythromycin
Mycoplasma pneumonia
Clinical evaluation
